The prevalence of homelessness among injection drug users with and without HIV infection
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Cross-sectional investigations of homelessness have many potential biases. Data from 2,452 individuals enrolled in a longitudinal cohort study of Baltimore, Maryland, residents recruited in 1988–1989 with a history of injection drug use were analyzed to identify the extent and determinants of homelessness. Proportions having ever experienced homelessness were compared across subgroups of injection drug users (IDUs) who were human immunodeficiency virus (HIV) negative, HIV positive, and HIV seroconverting. Logistic regression identified independent predictors of homelessness. In the cohort, 1,144 (46.7%) participants experienced homelessness during the course of the study. There were differences in prevalence of homelessness by serostatus: 42.4% (n=621) of participants who remained HIV negative were ever homeless, while 50.6% (n=346) of HIV-infected individuals and 58.9% (n=178) of those who seroconverted during the study were ever homeless (P<.001). Participants who consistently denied active injection drug use during follow-up were unlikely to experience homelessness (19%). Independent predictors of homelessness were male sex, HIV seroprevalence, and HIV seroconversion. Following participants over time captures more experiences of homelessness than cross-sectional studies and more accurately identifies risk characteristics. Our data suggest that homelessness is a significant problem among IDUs, especially those with HIV/AIDS.
- Koegel P, Burham MA, Baumohl J. The causes of homelessness. In: Baumohl J, ed.Homelessness in America. Phoenix, AZ: Oryx Press, 1996:31.
- Susser E, Stuening EL, Conover S. Psychiatric problems in homeless men: lifetime psychosis, substance use, and current distress.Arch Gen Psychiatry. 1989;46:845–850.
- Gelberg L, Linn LS, Leake BD. Mental health, alcohol and drug use, and criminal history among homeless adults.Am J Psychiatry. 1988;145:191–196.
- Robertson MJ, Zlotnick C, Westerfelt A. Drug use disorders and treatment contact among homeless adults in Alameda County, California.Am J Public Health. 1997;87: 221–228.
- Smereck GA, Hockman EM. Prevalence of HIV infection and HIV risk behaviors associated with living place: on-the-street homeless drug users as a special target population for public health intervention.Am J Drug Alcohol Abuse. 1998;12:299–319.
- Broers B, Morabia A, Hirschel B. A cohort study of drug users' compliance with zidovudine treatment.Arch Int Med. 1994;154:1121–1127.
- Celentano DD, Vlahov D, Cohn S, Shadle VM, Obasanjo B, Moore RD. Self-reported antiretroviral therapy in injection drug users.JAMA. 1998;280:544–546. CrossRef
- Strathdee SA, Palepu A, Cornelisse PGA, et al. Barriers to use of free antiretroviral therapy in injection drug users.JAMA. 1998;280:547–549. CrossRef
- Siegal HA, Carlson RG, Falck R, et al. HIV infection and risk behaviors among intravenous drug users in low seroprevalence areas in the Midwest.Am J Public Health. 1991; 81:1642–1644.
- Allen DM, Lehman JS, Green TA, Lindegren ML, Onorato IM, Forrester W, et al. HIV infection among homeless adults and runaway youth, United States, 1989–1992.AIDS. 1994;8:1593–1598.
- Zolopa AR, Hahn JA, Gorter R, et al. HIV and tuberculosis infection in San Francisco's homeless adults: prevalence and risk factors in a representative sample.JAMA. 1994; 272:455–461. CrossRef
- Paris NM, East RT, Toomey KE. HIV seroprevalence among Atlanta's homeless.J Health Care Poor Underserved. 1996;7:83–93.
- Torres RA, Altholz J, Brickner PW. Human immunodeficiency virus infection among homeless men in New York City shelter.Arch Int Med. 1990;150:2030–2036.
- Lieberman B. The state of AIDS housing in America. Paper presented at: Third National HIV/AIDS Housing Conference; September 16–18, 1998; Atlanta, GA.
- Low G, Shelter Partnership, Incorporated.A Report on Housing for Persons Living with HIV/AIDS in the City and the County of Los Angeles. Los Angeles, CA: Shelter Partnership; 1999:3.
- Weissman JS, Makadon HJ, Seige BR, Massagli HP, Gatsonis CA, Craven DE, et al. Changes in insurance status and access to care for persons with AIDS in the Boston Health Study.Am J Public Health. 1994;84:1997–2000.
- Link BG, Susser E, Stueve A, et al. Lifetime and five-year prevalence of homelessness in the United States.Am J Public Health. 1994;84:1907–1912.
- Rossi PH, Wright JD, Fisher GA, Willis G. The urban homeless: estimating composition and size.Science. 1987;235:1336–1341.
- McMurray-Avila M.Organizing Health Services for Homeless People: a Practical Guide. Nashville, TN: National HCH Council; 1997:81–82.
- Burt MR. Homelessness: definitions and counts. In: Baumohl J, ed.Homelessness in America. Phoenix, AZ: Oryx Press; 1996:15–23.
- Phelan JC, Link BG. Who are “the homeless”? Reconsidering the stability and composition of the homeless population.Am J Public Health. 1999;89(9):1334–1338.
- Vlahov D, Anthony JC, Munoz A, et al. The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods.J Drug Issues. 1991; 21:759–776.
- Solomon L, Stein M, Flynn C, et al. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS).J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:253–261.
- Hartz D, Banys P, Hall SM. Correlates of homelessness among substance abuse patients at a VA medical center.Hosp Community Psychiatry. 1994;45:491–493.
- Beardsley M, Clatts MC, Deren S, Davis WR, Tortu S. Homelessness and HIV-risk behaviors in a sample of New York City drug injectors.AIDS Public Polity J. 1992;7: 162–171.
- Samet JH, Libman H, Steger KA, et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic.Am J Med. 1992;92:495–501. CrossRef
- Patrick DM, Strathdee SA, Archibald CP, et al. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver.Int J STD AIDS. 1997;8:437–445. CrossRef
- Gallagher TC, Anderson RM, Koegel P, Gelberg L. Determinants of regular source of care among homeless adults in Los Angeles.Med Care. 1997;35:814–830. CrossRef
- Robertson MJ, Cousineau MR. Health status and access to health services among the urban homeless.Am J Public Health. 1986;76:561–563.
- Wood D, Valdez RB. Barriers to medical care for homeless families compared with housed poor families.Am J Dis Child. 1991;145:1109–1115.
- Bangsberg D, Tulsky DP, Hecht FM, Moss AR. Protease inhibitors in the homeless.JAMA. 1997;278:63–65. CrossRef
- Arno PS, Bonuck K. The impact of housing status on health care utilization among persons with HIV disease.J Health Care Poor Underserved. 1996;7:36–49.
- The prevalence of homelessness among injection drug users with and without HIV infection
Journal of Urban Health
Volume 77, Issue 4 , pp 678-687
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Injection drug use
- Author Affiliations
- 1. Center for Bioethics, Department of Medicine, University of Minnesota, Minnesota, USA
- 2. Department of Epidemiology, Infectious Diseases Program, Johns Hopkins School of Hygiene and Public Health, 615 North Wolfe Street, 21205, Baltimore, Maryland
- 3. Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, New York